• head_banner_01

Hot-selling Vancomycin Treat Mrsa - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Being supported by an innovative and experienced IT team, we could present technical support on pre-sales & after-sales service for 4-Bromophenylacetonitrile, Favipiravir Intermediate, N-(Benzyl-6-(4-Phenylbutoxy)-Hexane-1-Amine Hydrochloride, We usually concertrating on acquiring new creative products to fulfill request from our clientele all around the world. Be a part of us and let's make driving safer and funnier jointly!
Hot-selling Vancomycin Treat Mrsa - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex Detail:

Product Detail

NO.

Products

CAS No.

 Application

Key Quality Indicator

Purity

Isomer

SI *

Max *

Moisture

1

Fmoc-Lys(Mtt)-OH 167393-62-6 Lysine side chain modification

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤1.0%

2

Fmoc-Lys(Alloc)-OH 146982-27-6 Lysine side chain modification

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

3

Fmoc-Lys(ivDde)-OH 150629-67-7 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

4

Fmoc-Lys(Mmt)-OH 159857-60-0 Lysine side chain modification

≥98.0%

≤0.2%

≤0.3%

≤0.5%

≤1.0%

5

Fmoc-Glu-OtBu 84793-07-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

6

Glu-OtBu 45120-30-7 LiraglutideSemaglutide

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤1.0%

7

Octadecanedioic acid 871-70-5 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

8

Octadecanedioic acid   mono-tert-butyl ester 843666-40-0 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

9

tBu-OOC-C16-CO-Glu-OtBu 1188328-39-3 SemaglutideFragment A

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

10

AEEA 134978-97-5 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

11

AEEA-OH.HCl 134979-01-4 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

12

Fmoc-AEEA-OH 166108-71-0 SemaglutideAlbuvirtide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

13

Boc-AEEA-OH 108466-89-3 Semaglutide

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

14

AEEA-AEEA 1143516-05-5 Semaglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

15

Fmoc-AEEA-AEEA-OH 560088-89-3 SemaglutideFragment B

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

16

Octa(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH 1118767-16-0 SemaglutideFragment C

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

17

tBu-OOC-C16-CO-Glu(AEEA-AEEA-NHS)-OtBu 1118767-15-9 SemaglutideFragment D

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

18

Fmoc-Lys(tBu-OOC-C16-CO-Glu(AEEA-AEEA)-OtBu)-OH 1662688-20-1 Semaglutide Fragment E

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

19

Boc-His(Trt)-OH 32926-43-5 The end is histidine

≥99.5%

≤0.1%

≤0.1%

≤0.2%

≤4.0%

20

Fmoc-Aib-OH 94744-50-0 Semaglutide

≥99.5%

/

≤0.1%

≤0.2%

≤1.0%

21

Boc-His(Trt)-Aib-OH 2061897-68-3 Semaglutide

≥99.0%

≤0.1%

≤0.2%

≤0.3%

≤2.0%

22

Fmoc-Glu(OtBu)-Gly-OH 866044-63-5 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

23

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH 1169630-31-2? Semaglutide Fragment F

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

24

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-NHS 1169630-40-3 Semaglutide Fragment G

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

25

Fmoc-Arg(pbf)-Gly-OH 660846-80-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

26

Fmoc-Ala-Ala-OH 87512-31-0 GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

27

Fmoc-Thr(tBu)-Phe-OH 1260609-75-3 ? GLP-1 analogue

≥99.5%

≤0.1%

≤0.2%

≤0.2%

≤1.0%

28

Palmitic acid 1957/10/3 Liraglutide Fragment 1

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

29

Palm-Glu-OtBu NA Liraglutide Fragment 2

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

30

Palm-Glu(NES)-OtBu NA Liraglutide Fragment 3

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

31

Fmoc-Lys(Palm-Glu-OtBu)-OH 1491158-62-3 Liraglutide

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

32

Hexadecanedioic acid 505-54-4 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

33

Hexadecanedioic acid   mono-tert-butyl ester 843666-27-3 Insulin degludec

≥99.0%

/

≤0.2%

≤0.3%

≤1.0%

34

tBu-OOC-C14-CO-Glu-OtBu NA Insulin degludec Fragment I

≥98.0%

≤0.2%

≤0.5%

≤0.5%

≤1.0%

35

tBu-OOC-C14-CO-Glu(NES)-OtBu NA Insulin degludec Fragment II

≥96.0%

≤0.5%

≤1.0%

≤1.0%

≤1.0%

SI *= Specific Impurity

Max*= Max Unknown Impurity

Other Indicator:

- Acetic Acid: ≤0.02% (All Products)

- Ethyl Acetate: ≤0.5% (All Products)

- Alcohol: ≤0.5% (All Products)

Sanitization

Sanitization of distribution system, including loop and storage tank is performed by Pasteurization. When Pasteurization sanitization is performed, the purified water in tank is heated up to 80°C and start to circulate by distribution system. The sanitization lasts 1 hour after reaching 80°C. Sanitization is performed every quarter. The purified water system sanitization logbook was checked with no excursion highlighted.


Product detail pictures:

Hot-selling Vancomycin Treat Mrsa - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex detail pictures


Related Product Guide:

Gaining purchaser gratification is our company's aim eternally. We're going to make great initiatives to create new and top-quality products, satisfy your exclusive prerequisites and supply you with pre-sale, on-sale and after-sale solutions for Hot-selling Vancomycin Treat Mrsa - GLP-1 Protected Amino Acid for Side Chain Modification – Gentolex , The product will supply to all over the world, such as: Korea, Australia, Sheffield, We are seeking the chances to meet all the friends from both at home and abroad for the win-win cooperation. We sincerely hope to have long-term cooperation with all of you on the bases of mutual benefit and common development.
  • On this website, product categories is clear and rich, I can find the product I want very quickly and easily, this is really very good!
    5 Stars By Claire from British - 2018.10.01 14:14
    We are really happy to find such a manufacturer that ensuring product quality at the same time the price is very cheap.
    5 Stars By Eileen from Armenia - 2017.03.28 12:22
    Write your message here and send it to us